# FDA Inspection 1261875 - Aparna Kalyan, M.D. - February 18, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/aparna-kalyan-md/da4ea4b9-d098-4973-8880-7c78bb804bf3
Source feed: FDA_Inspections

> FDA Inspection 1261875 for Aparna Kalyan, M.D. on February 18, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261875
- Company Name: Aparna Kalyan, M.D.
- Inspection Date: 2025-02-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: Chicago District Office

## Related Documents

- [FDA Inspection 1261875 - 2025-02-18](https://www.globalkeysolutions.net/records/fda_inspections/aparna-kalyan-md/88bf9aee-c139-4441-9ddc-586100ef1d21)

Company: https://www.globalkeysolutions.net/companies/aparna-kalyan-md/b13a4163-f370-420a-b036-d98468d3b9b1

Office: https://www.globalkeysolutions.net/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669